当前位置：Public Access >页面
Chinese/English
CD133 CAR-T局部治疗结合放化疗在MGMT启动子甲基化阴性新诊断胶质母细胞瘤患者中的安全性及有效性的1期临床研究 CD133 CAR-T júbù zhìliáo jiéhé fàng huàliáo zài MGMT qǐdòng zǐ jiǎ jī huà yīnxìng xīn zhěnduàn jiāo zhí mǔ xìbāo liú huànzhě zhōng de ānquán xìng jí yǒuxiào xìng de 1 qī línchuáng yánjiū 60 / 5,000 A phase 1 clinical study on the safety and efficacy of CD133 CAR-T local therapy combined with chemoradiotherapy in patients with newly diagnosed glioblastoma with negative MGMT promoter methylation
Filter Options
Patient No. Patient Name Patient Gender
Sitting Education Date of enrollment FromTo
       More Options
Patient No Gender Date of enrollment Sitting Creater Operate
NO participants recorded。

提示：推荐使用chrome浏览器 并且在宽屏显示分辨率下使用系统。

Copyright(c) (2010-2013) .All rights reserved.临床试验公共管理平台 版权所有